Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 15 clinical trials
Effect of Sodium Alendronate on the Final Implant Stability.

evaluation of the final implant stability after its placement in sockets preserved with two different socket preservation materials

Accepts healthy volunteers
  • 0 views
  • 25 Dec, 2021
  • 1 location
Novel Combination Therapy for Osteoporosis in Men (Osteo-Men)

Osteoporotic fractures are a key health problem in older men. Although there are drugs approved to treat osteoporosis in men [bisphosphonates, denosumab, and teriparatide (TPTD) or PTH(1-34)], there is a lack of knowledge on how to use them effectively. TPTD is a potent bone anabolic drug, meaning that it builds …

  • 34 views
  • 26 Feb, 2022
  • 1 location
A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis

The purpose of this study is to evaluate the effect of alendronate sodium vitamin D3 tablets compared with placebo on the improvement of joint structure and joint pain in participants with knee

  • 0 views
  • 01 May, 2022
  • 3 locations
64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy

This early phase I pilot trial studies how well 64Cu-DOTA-alendronate positron emission tomography (PET) imaging work in localizing and characterizing breast calcifications (small calcium

calcium
copper
mastectomy
mammogram
cancer
  • 1 views
  • 23 Mar, 2022
  • 1 location
Effects of Romosozumab on Bone Density in Women With Anorexia Nervosa

extension study will offer subjects 12-month administration of open-label alendronate (an oral bisphosphonate) 70 mg once weekly after the initial 12 month administration of romosozumab or placebo. The

calcium
alendronate
bisphosphonate
vitamin d
estrogen
  • 8 views
  • 28 Nov, 2021
  • 1 location
The Optimal Sequential Therapy After Long Term Denosumab Treatment

This study intends to investigate whether Alendronate and Zoledronate can prevent bone mineral density loss after long-term treatment with Denosumab.

alendronate
denosumab
zoledronate
  • 0 views
  • 02 Nov, 2021
  • 1 location
Romosozumab in Women With Chronic SCI

). Participants will receive monthly injections of romosozumab during the first 12 months of the study. During the second year, participants will take oral alendronate tablets on a weekly basis.

spinal cord injury
diabetes
spinal cord disorder
alendronate
spinal cord
  • 0 views
  • 25 Mar, 2022
  • 1 location
Denosumab (DMAB) Discontinuation And Switching In Glucocorticoid-Induced Osteoporosis (GIOP): A Pilot Study

last denosumab dose) or weekly alendronate (6 months after last denosumab dose).

  • 0 views
  • 26 Dec, 2021
  • 1 location
Bisphosphonates for Prevention of Post-Denosumab Bone Loss

investigator will observe participants for a second year off bisphosphonate therapy to assess duration of response. The hypothesis is that bisphosphonate therapy with alendronate or zoledronic acid

bisphosphonate therapy
teriparatide
denosumab
zoledronic acid
bone mineral density
  • 78 views
  • 03 Mar, 2022
Comparative Antiresorptive Efficacy Discontinuation of Denosumab

relative efficacy of two oral antiresorptive medications that are FDA-approved for treatment of postmenopausal osteoporosis (alendronate and raloxifene) in preventing the rebound increase in bone turnover

raloxifene
denosumab
RANKL
abaloparatide
alendronate
  • 40 views
  • 02 May, 2021